[HTML][HTML] Genetics of cardiovascular disease: How far are we from personalized CVD risk prediction and management?

M Vrablik, D Dlouha, V Todorovova, D Stefler… - International journal of …, 2021 - mdpi.com
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

M Vrablik, D Dlouha, V Todorovova… - International …, 2021 - search.proquest.com
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

M Vrablik, D Dlouha, V Todorovova, D Stefler… - 2021 - agris.fao.org
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

[HTML][HTML] Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

M Vrablik, D Dlouha, V Todorovova… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

M Vrablik, D Dlouha, V Todorovova… - International …, 2021 - search.ebscohost.com
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

M Vrablik, D Dlouha, V Todorovova… - … Journal of Molecular …, 2021 - europepmc.org
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

[PDF][PDF] Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management

M Vrablik, D Dlouha, V Todorovova, D Stefler… - Int. J. Mol … - pdfs.semanticscholar.org
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

M Vrablik, D Dlouha, V Todorovova… - … Journal of Molecular …, 2021 - discovery.ucl.ac.uk
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

Genetics of cardiovascular disease: how far are we from personalized CVD risk prediction and management?

M Vrablik, D Dlouha, V Todorovova, D Stefler… - 2021 - cabidigitallibrary.org
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

[PDF][PDF] Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management

M Vrablik, D Dlouha, V Todorovova, D Stefler… - Int. J. Mol. Sci - scienceopen.com
Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …